The Autism candidate gene neurobeachin encodes a scaffolding protein implicated in membrane trafficking and signaling

Current Molecular Medicine

Volumn 11, Issue 3, 2011, Pages 204-217

  Volders, K ^a   Nuytens, K ^a   Creemers, J W M ^a  

^a UNIVERSITY OF LEUVEN   (Belgium)

Author keywords

Autism; EGFR; Neurobeachin; Notch; Regulated secretion; Rugose; SEL 2; Synapse

Indexed keywords

BRAIN DERIVED NEUROTROPHIC FACTOR; CAENORHABDITIS ELEGANS PROTEIN; CYCLIC AMP DEPENDENT PROTEIN KINASE; EPIDERMAL GROWTH FACTOR RECEPTOR; LIPOPOLYSACCHARIDE RESPONSIVE VESICLE TRAFFICKING BEIGE-LIKE ANCHOR PROTEIN; MONOAMINE DERIVATIVE; NERVE GROWTH FACTOR; NEUROBEACHIN; NEUROPEPTIDE; NEUROTRANSMITTER; NEUROTROPHIN; NOTCH RECEPTOR; PROTEIN; PROTEIN BEACH; PROTEIN SEL 2; RUGOSE PROTEIN; SCAFFOLD PROTEIN; SNARE PROTEIN; UNCLASSIFIED DRUG;

ARTICLE; AUTISM; BINDING AFFINITY; CAENORHABDITIS ELEGANS; CELL LINE; CELL PROLIFERATION; CELL STRUCTURE; CHROMOSOME 13Q; CHROMOSOME ANALYSIS; CHROMOSOME DELETION 13; CHROMOSOME TRANSLOCATION; COMMUNICATION DISORDER; DENSE CORE SECRETORY GRANULES; DROSOPHILA; DROSOPHILA MELANOGASTER; ENDOSOME; EPILEPSY; GENE DELETION; GENE IDENTIFICATION; GENE LOCATION; GENETIC CODE; GOLGI COMPLEX; HOMOZYGOTE; HUMAN; MONOCLONAL IMMUNOGLOBULINEMIA; MOUSE; MULTIPLE MYELOMA; NEOPLASM; NERVE CELL; NERVE CELL PLASTICITY; NEUROTRANSMITTER RELEASE; NONHUMAN; PROTEIN ANALYSIS; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN PROTEIN INTERACTION; PROTEIN STRUCTURE; SECRETORY GRANULE; SEQUENCE HOMOLOGY; SIGNAL TRANSDUCTION; SOCIAL INTERACTION; STEREOTYPY; SYNAPTIC TRANSMISSION; THROMBOCYTE;

CAENORHABDITIS ELEGANS;

EID: 79953326969     PISSN: 15665240     EISSN: None     Source Type: Journal    
DOI: 10.2174/156652411795243432     Document Type: Article

References (142)

1. th edition - Text Revision (DSM-IV-TR): American Psychiatric Association: Washington, DC; 2000.
2. Fombonne E. Epidemiology of pervasive developmental disorders. Pediatr Res 2009; 65(6): 591-598.
3. Freitag C. The genetics of autistic disorders and its clinical relevance: a review of the literature. Mol Psychiatry 2007; 12(1): 2-22.
4. Abrahams B, Geschwind D. Advances in autism genetics: on the threshold of a new neurobiology. Nat Rev Genet 2008; 9(5): 341-355.
5. Steyaert J, De la Marche W. What's new in autism? Eur J Pediatr 2008; 167(10): 1091-1101.
6. Bailey A, Le Couteur A, Gottesman I, et al. Autism as a strongly genetic disorder: evidence from a British twin study. Psychol Med 1995; 25(1): 63-77.
7. Cook EJ, Scherer S. Copy-number variations associated with neuropsychiatric conditions. Nature 2008; 455(7215): 919-923.
8. Vorstman J, Staal W, van Daalen E, van Engeland H, Hochstenbach P, Franke L. Identification of novel autism candidate regions through analysis of reported cytogenetic abnormalities associated with autism. Mol Psychiatry 2006; 11(1): 1, 18-28.
9. Szatmari P, Paterson AD, Zwaigenbaum L, et al. Mapping autism risk loci using genetic linkage and chromosomal rearrangements. Nat Genet 2007; 39(3): 319-328.
10. Sebat J, Lakshmi B, Malhotra D, et al. Strong association of de novo copy number mutations with autism. Science 2007; 316(5823): 445-449.
11. Castermans D, Wilquet V, Parthoens E, et al. The neurobeachin gene is disrupted by a translocation in a patient with idiopathic autism. J Med Genet 2003; 40(5): 352-356.
12. Castermans D, Wilquet V, Steyaert J, Van de Ven W, Fryns JP, Devriendt K. Chromosomal anomalies in individuals with autism: a strategy towards the identification of genes involved in autism. Autism 2004; 8(2): 141-161.
13. Castermans D, Thienpont B, Volders K, et al. Position effect leading to haploinsufficiency in a mosaic ring chromosome 14 in a boy with autism. Eur J Hum Genet 2008; 16(10): 1187-1192.
14. Castermans D, Vermeesch JR, Fryns JP, et al. Identification and characterization of the TRIP8 and REEP3 genes on chromosome 10q21.3 as novel candidate genes for autism. Eur J Hum Genet 2007; 15(4): 422-431.
15. Wang K, Zhang H, Ma D, et al. Common genetic variants on 5p14.1 associate with autism spectrum disorders. Nature 2009; 459(7246): 528-533.
16. Weiss LA, Arking DE, Daly MJ, Chakravarti A, Consortium GDPoJHtA. A genome-wide linkage and association scan reveals novel loci for autism. Nature 2009; 461(7265): 802-808.
17. Weiss LA. Autism genetics: emerging data from genomewide copy-number and single nucleotide polymorphism scans. Expert Rev Mol Diagn 2009; 9(8): 795-803.
18. Bourgeron T. A synaptic trek to autism. Curr Opin Neurobiol 2009; 19(2): 231-234.
19. Jamain S, Quach H, Betancur C, et al. Mutations of the Xlinked genes encoding neuroligins NLGN3 and NLGN4 are associated with autism. Nat Genet 2003; 34(1): 27-29.
20. Laumonnier F, Bonnet-Brilhault F, Gomot M, et al. X-linked mental retardation and autism are associated with a mutation in the NLGN4 gene, a member of the neuroligin family. Am J Hum Genet 2004; 74(3): 552-557.
21. Tabuchi K, Blundell J, Etherton MR, et al. A neuroligin-3 mutation implicated in autism increases inhibitory synaptic transmission in mice. Science 2007; 318(5847): 71-76.
22. Kim HG, Kishikawa S, Higgins AW, et al. Disruption of neurexin 1 associated with autism spectrum disorder. Am J Hum Genet 2008; 82(1): 199-207.
23. Etherton MR, Blaiss CA, Powell CM, Sudhof TC. Mouse neurexin-1alpha deletion causes correlated electrophysiological and behavioral changes consistent with cognitive impairments. Proc Natl Acad Sci USA 2009; 106(42): 17998-18003.
24. Durand CM, Betancur C, Boeckers TM, et al. Mutations in the gene encoding the synaptic scaffolding protein SHANK3 are associated with autism spectrum disorders. Nat Genet 2007; 39(1): 25-27.
25. Alarcón M, Abrahams BS, Stone JL, et al. Linkage, association, and gene-expression analyses identify CNTNAP2 as an autism-susceptibility gene. Am J Hum Genet 2008; 82(1): 150-159.
26. Arking DE, Cutler DJ, Brune CW, et al. A common genetic variant in the neurexin super family member CNTNAP2 increases familial risk of autism. Am J Hum Genet 2008; 82(1): 160-164.
27. Vernes S, Newbury D, Abrahams B, et al. A functional genetic link between distinct developmental language disorders. N Engl J Med 2008; 359(22): 2337-2345.
28. Kwon CH, Luikart BW, Powell CM, et al. Pten regulates neuronal arborization and social interaction in mice. Neuron 2006; 50(3): 377-388.
29. Williams CA, Dagli A, Battaglia A. Genetic disorders associated with macrocephaly. Am J Med Genet A 2008; 146A(15): 2023-2037.
30. Tavazoie SF, Alvarez VA, Ridenour DA, Kwiatkowski DJ, Sabatini BL. Regulation of neuronal morphology and function by the tumor suppressors Tsc1 and Tsc2. Nat Neurosci 2005; 8(12): 1727-1734.
31. Barrett S, Beck J, Bernier R, et al. An autosomal genomic screen for autism. Collaborative linkage study of autism. Am J Med Genet 1999; 88(6): 609-615.
32. Bradford Y, Haines J, Hutcheson H, et al. Incorporating language phenotypes strengthens evidence of linkage to autism. Am J Med Genet 2001; 105(6): 539-547.
33. Smith M, Woodroffe A, Smith R, et al. Molecular genetic delineation of a deletion of chromosome 13q12-->q13 in a patient with autism and auditory processing deficits. Cytogenet Genome Res 2002; 98(4): 233-239.
34. Reddy K. Cytogenetic abnormalities and fragile-X syndrome in Autism Spectrum Disorder. BMC Med Genet 2005; 6: 3.
35. Ritvo E, Mason-Brothers A, Menkes J, Sparkes R. Association of autism, retinoblastoma, and reduced esterase D activity. Arch Gen Psychiatry 1988; 45(6): 600.
36. Savelyeva L, Sagulenko E, Schmitt J, Schwab M. The neurobeachin gene spans the common fragile site FRA13A. Hum Genet 2006; 118(5): 551-558.
37. McAvoy S, Ganapathiraju S, Ducharme-Smith A, et al. Nonrandom inactivation of large common fragile site genes in different cancers. Cytogenet Genome Res 2007; 118(2-4): 260-269.
38. O'Neal J, Gao F, Hassan A, et al. Neurobeachin (NBEA) is a target of recurrent interstitial deletions at 13q13 in patients with MGUS and multiple myeloma. Exp Hematol 2009; 37(2): 234-244.
39. Savelyeva L, Sagulenko E, Schmitt J, Schwab M. Lowfrequency common fragile sites: link to neuropsychiatric disorders? Cancer Lett 2006; 232(1): 58-69.
40. Castermans D, Volders K, Crepel A, et al. SCAMP5, NBEA and AMISYN: three candidate genes for autism involved in secretion of large dense-core vesicles. Hum Mol Genet 2010; 19(7): 1368-1378.
41. Feng J, Schroer R, Yan J, et al. High frequency of neurexin 1beta signal peptide structural variants in patients with autism. Neurosci Lett 2006; 409(1): 10-13.
42. Wang X, Herberg FW, Laue MM, et al. Neurobeachin: A protein kinase A-anchoring, beige/Chediak-higashi protein homolog implicated in neuronal membrane traffic. J Neurosci 2000; 20(23): 8551-8565.
43. De Lozanne A. The role of BEACH proteins in Dictyostelium. Traffic 2003; 4(1): 6-12.
44. Karim MA, Suzuki K, Fukai K, et al. Apparent genotypephenotype correlation in childhood, adolescent, and adult Chediak-Higashi syndrome. Am J Med Genet 2002; 108(1): 16-22.
45. Karim MA, Nagle DL, Kandil HH, Bürger J, Moore KJ, Spritz RA. Mutations in the Chediak-Higashi syndrome gene (CHS1) indicate requirement for the complete 3801 amino acid CHS protein. Hum Mol Genet 1997; 6(7): 1087-1089.
46. Certain S, Barrat F, Pastural E, et al. Protein truncation test of LYST reveals heterogenous mutations in patients with Chediak-Higashi syndrome. Blood 2000; 95(3): 979-983.
47. Manoli I, Golas G, Westbroek W, et al. Chediak-Higashi syndrome with early developmental delay resulting from paternal heterodisomy of chromosome 1. Am J Med Genet A 2010; 152A(6): 1474-1483.
48. Nagle D, Karim M, Woolf E, et al. Identification and mutation analysis of the complete gene for Chediak-Higashi syndrome. Nat Genet 1996; 14(3): 307-311.
49. Fukai K, Oh J, Karim M, et al. Homozygosity mapping of the gene for Chediak-Higashi syndrome to chromosome 1q42- q44 in a segment of conserved synteny that includes the mouse beige locus (bg). Am J Hum Genet 1996; 59(3): 620-624.
50. Gebauer D, Li J, Jogl G, Shen Y, Myszka D, Tong L. Crystal structure of the PH-BEACH domains of human LRBA/BGL. Biochemistry 2004; 43(47): 14873-14880.
51. Jogl G, Shen Y, Gebauer D, et al. Crystal structure of the BEACH domain reveals an unusual fold and extensive association with a novel PH domain. EMBO J 2002; 21(18): 4785-4795.
52. Blomberg N, Baraldi E, Nilges M, Saraste M. The PH superfold: a structural scaffold for multiple functions. Trends Biochem Sci 1999; 24(11): 441-445.
53. Lemmon M. Membrane recognition by phospholipid-binding domains. Nat Rev Mol Cell Biol 2008; 9(2): 99-111.
54. Neer EJ, Schmidt CJ, Nambudripad R, Smith TF. The ancient regulatory-protein family of WD-repeat proteins. Nature 1994; 371(6495): 297-300.
55. Smith TF, Gaitatzes C, Saxena K, Neer EJ. The WD repeat: a common architecture for diverse functions. Trends Biochem Sci 1999; 24(5): 181-185.
56. Adam-Klages S, Adam D, Wiegmann K, et al. FAN, a novel WD-repeat protein, couples the p55 TNF-receptor to neutral sphingomyelinase. Cell 1996; 86(6): 937-947.
57. Ségui B, Andrieu-Abadie N, Adam-Klages S, et al. CD40 signals apoptosis through FAN-regulated activation of the sphingomyelin-ceramide pathway. J Biol Chem 1999; 274(52): 37251-37258.
58. Wang J, Howson J, Haller E, Kerr W. Identification of a novel lipopolysaccharide-inducible gene with key features of both A kinase anchor proteins and chs1/beige proteins. J Immunol 2001; 166(7): 4586-4595.
59. De Camilli P, Moretti M, Donini SD, Walter U, Lohmann SM. Heterogeneous distribution of the cAMP receptor protein RII in the nervous system: evidence for its intracellular accumulation on microtubules, microtubule-organizing centers, and in the area of the Golgi complex. J Cell Biol 1986; 103(1): 189-203.
60. Muñiz M, Martín ME, Hidalgo J, Velasco A. Protein kinase A activity is required for the budding of constitutive transport vesicles from the trans-Golgi network. Proc Natl Acad Sci USA 1997; 94(26): 14461-14466.
61. Ohashi M, Huttner WB. An elevation of cytosolic protein phosphorylation modulates trimeric G-protein regulation of secretory vesicle formation from the trans-Golgi network. J Biol Chem 1994; 269(40): 24897-24905.
62. Burgess A, Mornon JP, de Saint-Basile G, Callebaut I. A concanavalin A-like lectin domain in the CHS1/LYST protein, shared by members of the BEACH family. Bioinformatics 2009; 25(10): 1219-1222.
63. Breidenbach M, Brunger A. New insights into clostridial neurotoxin-SNARE interactions. Trends Mol Med 2005; 11(8): 377-381.
64. Lalli G, Bohnert S, Deinhardt K, Verastegui C, Schiavo G. The journey of tetanus and botulinum neurotoxins in neurons. Trends Microbiol 2003; 11(9): 431-437.
65. Tewari R, Bailes E, Bunting K, Coates J. Armadillo-repeat protein functions: questions for little creatures. Trends Cell Biol 2010; 20(8): 470-481.
66. Wang J, Gamsby J, Highfill S, et al. Deregulated expression of LRBA facilitates cancer cell growth. Oncogene 2004; 23(23): 4089-4097.
67. Fujishima N, Hirokawa M, Aiba N, et al. Gene expression profiling of human erythroid progenitors by micro-serial analysis of gene expression. Int J Hematol 2004; 80(3): 239-245.
68. Tozlu S, Girault I, Vacher S, et al. Identification of novel genes that co-cluster with estrogen receptor alpha in breast tumor biopsy specimens, using a large-scale real-time reverse transcription-PCR approach. Endocr Relat Cancer 2006; 13(4): 1109-1120.
69. UCSC Genome Bioinformatics. Available from: http://genome.ucsc.edu/
70. Chen J, Lu Y, Xu J, et al. Identification and characterization of NBEAL1, a novel human neurobeachin-like 1 protein gene from fetal brain, which is up regulated in glioma. Brain Res Mol Brain Res 2004; 125(1-2): 147-155.
71. Han J, Baker N, Rubin C. Molecular characterization of a novel a kinase anchor protein from Drosophila melanogaster. J Biol Chem 1997; 272(42): 26611-26619.
72. Shamloula H, Mbogho M, Pimentel A, et al. Rugose (rg), a Drosophila A kinase anchor protein, is required for retinal pattern formation and interacts genetically with multiple signaling pathways. Genetics 2002; 161(2): 693-710.
73. Schreiber S, Preiss A, Nagel A, Wech I, Maier D. Genetic screen for modifiers of the rough eye phenotype resulting from overexpression of the Notch antagonist hairless in Drosophila. Genesis 2002; 33(3): 141-152.
74. Shamloula H. Mutation in rugose gene locus affects the pigment cell number and alters the optic lobe phenotype in the Drosophila visual system. J Egypt Soc Parasitol 2003; 33(3): 955-967.
75. Wech I, Nagel A. Mutations in rugose promote cell typespecific apoptosis in the Drosophila eye. Cell Death Differ 2005; 12(2): 145-152.
76. Doroquez DB, Rebay I. Signal integration during development: mechanisms of EGFR and Notch pathway function and cross-talk. Crit Rev Biochem Mol Biol 2006; 41(6): 339-385.
77. Artavanis-Tsakonas S, Rand M, Lake R. Notch signaling: cell fate control and signal integration in development. Science 1999; 284(5415): 770-776.
78. de Souza N, Vallier L, Fares H, Greenwald I. SEL-2, the C. elegans neurobeachin/LRBA homolog, is a negative regulator of lin-12/Notch activity and affects endosomal traffic in polarized epithelial cells. Development 2007; 134(4): 691-702.
79. Le Borgne R. Regulation of Notch signalling by endocytosis and endosomal sorting. Curr Opin Cell Biol 2006; 18(2): 213-222.
80. Sorkin A, Goh L. Endocytosis and intracellular trafficking of ErbBs. Exp Cell Res 2008; 314(17): 3093-3106.
81. Aguirre A, Rubio M, Gallo V. Notch and EGFR pathway interaction regulates neural stem cell number and selfrenewal. Nature 2010; 467(7313): 323-327.
82. Lathia J, Mattson M, Cheng A. Notch: from neural development to neurological disorders. J Neurochem 2008; 107(6): 1471-1481.
83. Louvi A, Artavanis-Tsakonas S. Notch signalling in vertebrate neural development. Nat Rev Neurosci 2006; 7(2): 93-102.
84. Wong R, Guillaud L. The role of epidermal growth factor and its receptors in mammalian CNS. Cytokine Growth Factor Rev 2004; 15(2-3): 147-156.
85. Liu B, Neufeld A. Activation of epidermal growth factor receptors in astrocytes: from development to neural injury. J Neurosci Res 2007; 85(16): 3523-3529.
86. Seno M, Hu P, Gwadry F, et al. Gene and miRNA Expression Profiles in Autism Spectrum Disorders. Brain Res 2010 Sep. [Epub ahead of print]
87. Hassel S, Eichner A, Yakymovych M, Hellman U, Knaus P, Souchelnytskyi S. Proteins associated with type II bone morphogenetic protein receptor (BMPR-II) and identified by two-dimensional gel electrophoresis and mass spectrometry. Proteomics 2004; 4(5): 1346-1358.
88. Sieber C, Kopf J, Hiepen C, Knaus P. Recent advances in BMP receptor signaling. Cytokine Growth Factor Rev. England 2009. p. 343-355.
89. Drach J, Kaufmann H, Urbauer E, Schreiber S, Ackermann J, Huber H. The biology of multiple myeloma. J Cancer Res Clin Oncol 2000; 126(8): 441-447.
90. Fonseca R, Bergsagel PL, Drach J, et al. International Myeloma Working Group molecular classification of multiple myeloma: spotlight review. Leukemia 2009; 23(12): 2210-2221.
91. Burkhart DL, Sage J. Cellular mechanisms of tumour suppression by the retinoblastoma gene. Nat Rev Cancer 2008; 8(9): 671-682.
92. Zhan F, Barlogie B, Arzoumanian V, et al. Gene-expression signature of benign monoclonal gammopathy evident in multiple myeloma is linked to good prognosis. Blood 2007; 109(4): 1692-1700.
93. Nefedova Y, Sullivan DM, Bolick SC, Dalton WS, Gabrilovich DI. Inhibition of Notch signaling induces apoptosis of myeloma cells and enhances sensitivity to chemotherapy. Blood 2008; 111(4): 2220-2229.
94. Miller WR. Regulatory subunits of PKA and breast cancer. Ann N Y Acad Sci 2002; 968: 37-48.
95. Liu Y, Krantz DE, Waites C, Edwards RH. Membrane trafficking of neurotransmitter transporters in the regulation of synaptic transmission. Trends Cell Biol 1999; 9(9): 356-363.
96. Olkkonen VM, Ikonen E. Genetic defects of intracellularmembrane transport. N Engl J Med 2000; 343(15): 1095-1104.
97. Salaun C, James DJ, Chamberlain LH. Lipid rafts and the regulation of exocytosis. Traffic 2004; 5(4): 255-264.
98. Morgan A. Exocytosis. Essays Biochem 1995; 30: 77-95.
99. Burgoyne RD, Morgan A. Secretory granule exocytosis. Physiol Rev 2003; 83(2):581-632.
100. Chuang JZ, Milner TA, Zhu M, Sung CH. A 29 kDa intracellular chloride channel p64H1 is associated with large dense-core vesicles in rat hippocampal neurons. J Neurosci 1999; 19(8): 2919-2928.
101. Thiele C, Huttner WB. Protein and lipid sorting from the trans-Golgi network to secretory granules-recent developments. Semin Cell Dev Biol 1998; 9(5): 511-516.
102. Michel JJ, Scott JD. AKAP mediated signal transduction. Annu Rev Pharmacol Toxicol 2002; 42: 235-257.
103. Park Y, Kim KT. Short-term plasticity of small synaptic vesicle (SSV) and large dense-core vesicle (LDCV) exocytosis. Cell Signal 2009; 21(10): 1465-1470.
104. Su Y, Balice-Gordon RJ, Hess DM, et al. Neurobeachin is essential for neuromuscular synaptic transmission. J Neurosci 2004; 24(14): 3627-3636.
105. Medrihan L, Rohlmann A, Fairless R, et al. Neurobeachin, a protein implicated in membrane protein traffic and autism, is required for the formation and functioning of central synapses. J Physiol 2009; 587(Pt 21): 5095-5106
106. Bonanomi D, Benfenati F, Valtorta F. Protein sorting in the synaptic vesicle life cycle. Prog Neurobiol 2006; 80(4): 177-217.
107. Rubenstein JL. Three hypotheses for developmental defects that may underlie some forms of autism spectrum disorder. Curr Opin Neurol 2010; 23(2): 118-123.
108. Tuchman R, Cuccaro M, Alessandri M. Autism and epilepsy: Historical perspective. Brain Dev. 2010 May 24.
109. Naylor DE. Glutamate and GABA in the balance: convergent pathways sustain seizures during status epilepticus. Epilepsia 2010; 51 (Suppl 3): 106-109.
110. Liao H, Zhang J, Shestopal S, Szabo G, Castle A, Castle D. Nonredundant function of secretory carrier membrane protein isoforms in dense core vesicle exocytosis. Am J Physiol Cell Physiol 2008; 294(3): C797-C809.
111. Dani VS, Chang Q, Maffei A, Turrigiano GG, Jaenisch R, Nelson SB. Reduced cortical activity due to a shift in the balance between excitation and inhibition in a mouse model of Rett syndrome. Proc Natl Acad Sci USA 2005; 102(35): 12560-12565.
112. Nelson ED, Kavalali ET, Monteggia LM. MeCP2-dependent transcriptional repression regulates excitatory neurotransmission. Curr Biol 2006; 16(7): 710-716.
113. Hagerman RJ, Ono MY, Hagerman PJ. Recent advances in fragile X: a model for autism and neurodegeneration. Curr Opin Psychiatry 2005; 18(5): 490-496.
114. Kaufmann WE, Cortell R, Kau AS, et al. Autism spectrum disorder in fragile X syndrome: communication, social interaction, and specific behaviors. Am J Med Genet A 2004; 129A(3): 225-234.
115. Gibson JR, Bartley AF, Hays SA, Huber KM. Imbalance of neocortical excitation and inhibition and altered UP states reflect network hyperexcitability in the mouse model of fragile X syndrome. J Neurophysiol 2008; 100(5): 2615-2626.
116. Fagiolini M, Fritschy JM, Low K, Mohler H, Rudolph U, Hensch TK. Specific GABAA circuits for visual cortical plasticity. Science 2004; 303(5664): 1681-1683.
117. Katagiri H, Fagiolini M, Hensch TK. Optimization of somatic inhibition at critical period onset in mouse visual cortex. Neuron 2007; 53(6): 805-812.
118. Nakamura K, Anitha A, Yamada K, et al. Genetic and expression analyses reveal elevated expression of syntaxin 1A (STX1A) in high functioning autism. Int J Neuropsychopharmacol 2008; 11(8): 1073-1084.
119. Rubenstein JL, Merzenich MM. Model of autism: increased ratio of excitation/inhibition in key neural systems. Genes Brain Behav 2003; 2(5): 255-267.
120. Ramocki MB, Zoghbi HY. Failure of neuronal homeostasis results in common neuropsychiatric phenotypes. Nature 2008; 455(7215): 912-918.
121. Iwaniuk KM, Schira J, Weinhold S, et al. Network-like impact of MicroRNAs on neuronal lineage differentiation of unrestricted somatic stem cells from human cord blood (USSC). Stem Cells Dev 2010 Nov 10. [Epub ahead of print]
122. Creemers JW, Pritchard LE, Gyte A, et al. Agouti-related protein is posttranslationally cleaved by proprotein convertase 1 to generate agouti-related protein (AGRP)83-132: interaction between AGRP83-132 and melanocortin receptors cannot be influenced by syndecan-3. Endocrinology 2006; 147(4): 1621-1631.
123. Scales SJ, Hesser BA, Masuda ES, Scheller RH. Amisyn, a novel syntaxin-binding protein that may regulate SNARE complex assembly. J Biol Chem 2002; 277(31): 28271-28279.
124. Liu L, Liao H, Castle A, et al. SCAMP2 interacts with Arf6 and phospholipase D1 and links their function to exocytotic fusion pore formation in PC12 cells. Mol Biol Cell 2005; 16(10): 4463-4472.
125. Guo Z, Liu L, Cafiso D, Castle D. Perturbation of a very late step of regulated exocytosis by a secretory carrier membrane protein (SCAMP2)-derived peptide. J Biol Chem 2002; 277(38): 35357-35363.
126. Noh JY, Lee H, Song S, et al. SCAMP5 links endoplasmic reticulum stress to the accumulation of expanded polyglutamine protein aggregates via endocytosis inhibition. J Biol Chem 2009; 284(17): 11318-11325.
127. Short B, Barr FA. Membrane fusion: caught in a trap. Curr Biol 2004; 14(5): R187-R189.
128. Varlamov O, Volchuk A, Rahimian V, et al. i-SNAREs: inhibitory SNAREs that fine-tune the specificity of membrane fusion. J Cell Biol 2004; 164(1): 79-88.
129. Gerst JE. SNARE regulators: matchmakers and matchbreakers. Biochim Biophys Acta 2003; 1641(2-3): 99-110.
130. Marash M, Gerst JE. t-SNARE dephosphorylation promotes SNARE assembly and exocytosis in yeast. EMBO J. 2001; 20(3): 411-421.
131. Marash M, Gerst JE. Phosphorylation of the autoinhibitory domain of the Sso t-SNAREs promotes binding of the Vsm1 SNARE regulator in yeast. Mol Biol Cell 2003; 14(8): 3114-3125.
132. Baba T, Sakisaka T, Mochida S, Takai Y. PKA-catalyzed phosphorylation of tomosyn and its implication in Ca2+- dependent exocytosis of neurotransmitter. J Cell Biol 2005; 170(7): 1113-1125.
133. Kumar RA, Sudi J, Babatz TD, et al. A de novo 1p34.2 microdeletion identifies the synaptic vesicle gene RIMS3 as a novel candidate for autism. J Med Genet 2010; 47(2): 81-90.
134. Reed GL, Fitzgerald ML, Polgar J. Molecular mechanisms of platelet exocytosis: insights into the secrete life of thrombocytes. Blood 2000; 96(10): 3334-3342.
135. Cook EH, Leventhal BL. The serotonin system in autism. Curr Opin Pediatr 1996; 8(4): 348-354.
136. Burgess NK, Sweeten TL, McMahon WM, Fujinami RS. Hyperserotoninemia and altered immunity in autism. J Autism Dev Disord 2006; 36(5): 697-704.
137. Lee R, Kermani P, Teng KK, Hempstead BL. Regulation of cell survival by secreted proneurotrophins. Science 2001; 294(5548): 1945-1948.
138. Miyazaki K, Narita N, Sakuta R, et al. Serum neurotrophin concentrations in autism and mental retardation: a pilot study. Brain Dev 2004; 26(5): 292-295.
139. Nelson KB, Grether JK, Croen LA, et al. Neuropeptides and neurotrophins in neonatal blood of children with autism or mental retardation. Ann Neurol 2001; 49(5): 597-606.
140. Anney R, Klei L, Pinto D, et al. A genome-wide scan for common alleles affecting risk for autism. Hum Mol Genet 2010; 19(20): 4072-4082.
141. Sadakata T, Furuichi T. Developmentally regulated Ca2+- dependent activator protein for secretion 2 (CAPS2) is involved in BDNF secretion and is associated with autism susceptibility. Cerebellum 2009; 8(3): 312-322.
142. Sadakata T, Furuichi T. Ca(2+)-dependent activator protein for secretion 2 and autistic-like phenotypes. Neurosci Res 2010; 67(3): 197-202.